Science & Enterprise subscription

Follow us on Twitter

  • A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV… https://t.co/Gl4q8GAZBg
    about 2 hours ago
  • New post on Science and Enterprise: Sensor in Works Detecting Covid-19 Airborne Virus https://t.co/gQ7LuZ5Qv1 #Science #Business
    about 3 hours ago
  • A company designing microscale robotic devices to deliver therapies to the central nervous system began work in pub… https://t.co/SUbHXwULXG
    about 4 hours ago
  • New post on Science and Enterprise: Micro Robotic Neuro Therapy Company Underway https://t.co/Lfm9Nysgd3 #Science #Business
    about 4 hours ago
  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 1 day ago

Please share Science & Enterprise

Trial OKed for Rare Disease Gene Therapy

Nerve cells illustration

A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy

Device-Aided Covid-19 Vaccine Invokes Immune Response

SARS-CoV-2 and cell

Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response. . . . → Read More: Device-Aided Covid-19 Vaccine Invokes Immune Response

Gates Funding Home-Based Crispr Covid-19 Diagnostic

Crispr graphic

A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home. . . . → Read More: Gates Funding Home-Based Crispr Covid-19 Diagnostic

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy

Bayer Gains Lung Cancer Therapy in $670M Deal

Lung cancer illustration

Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics. . . . → Read More: Bayer Gains Lung Cancer Therapy in $670M Deal

Small Biz Grant Funds AI Repro Health Technology

Glasses, computer screens

A company developing health metrics with artificial intelligence received a grant to better understand polycystic ovary syndrome, an endocrine disorder affecting women. . . . → Read More: Small Biz Grant Funds AI Repro Health Technology

Inexpensive Chip Detects Covid-19, Other Pathogens

TriSilix chip

A small silicon lab-on-a-chip device costing about $0.35 to make is shown in lab tests to quickly detect SARS-CoV-2 viruses and infectious bacteria. . . . → Read More: Inexpensive Chip Detects Covid-19, Other Pathogens

Simpler Method Devised to Validate Covid-19 Tests

Covid-19 testing

An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19. . . . → Read More: Simpler Method Devised to Validate Covid-19 Tests

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Wheat Genome Study IDs Critical Genes, Traits

Curtis Pozniak in wheat field

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits